The chart below shows how SNN performed 10 days before and after its earnings report, based on data from the past quarters. Typically, SNN sees a -12.06% change in stock price 10 days leading up to the earnings, and a +6.15% change 10 days following the report. On the earnings day itself, the stock moves by +6.96%. This data can give you a slight idea of what to expect for the next quarter's release.
Positive
Quarterly Revenue Growth: We announced underlying revenue growth of 4% in the quarter.
Quarterly Revenue Performance: Revenue in the quarter was $1.4 billion with 4% underlying growth.
Revenue Growth and Margin Expansion: We expect to finish the year with underlying revenue growth of 4.5% and trading margin expansion of up to 50 basis points.
Operational Improvements Impact Revenue: We have made significant operational improvements around product supply and commercial execution over the last year, and these are now starting to come through in revenue.
Best Growth Quarter: Advanced Wound Management delivered its best growth quarter this year.
Negative
Quarterly Revenue Performance: Revenue in the quarter was $1.4 billion with 4% underlying growth.
Orthopedic Market Challenges: China's orthopedic market showed unexpected headwinds, impacting overall growth by almost 2 percentage points.
Price Impact of VBP: The expected price impact of VBP in sports has yet to materialize, affecting volume benefits.
Margin Pressure Forecast: The lower development of VBP volume benefits is likely to contribute more margin pressure in 2025 than previously assumed.
Revised Revenue Growth Outlook: We now expect to finish the year with underlying revenue growth of around 4.5%, below our previous guidance range of 5% to 6%.
Smith & Nephew plc (SNN) Q3 2024 Earnings Conference Call Transcript
SNN.N
0.8%